Company Tagline
From promising to validated immuno-therapeutics: GEM design and humanization, profiling solutions for your candidate
Industry Category
Business Keywords
Company Description
JC Discovery is a leading biotechnology research company dedicated to accelerating the development and validation of innovative immunotherapeutics. Leveraging a science-driven approach and a unique combination of expertise derived from its founding company, CIPHE (Center of ImmunoPHEnomics), JC Discovery offers unparalleled services to pharmaceutical and biotech companies. JC Discovery's commitment to excellence is reflected in its state-of-the-art platform and BSL3 laboratory, enabling efficient and innovative solutions for validating drug candidates early in the development process.
Located at 163 Av. de Luminy, Marseille, 13007, FR, JC Discovery specializes in elucidating mechanisms of action and interactions, identifying, validating, and prioritizing new therapeutic targets within immuno-oncology, inflammatory, autoimmune, and infectious diseases. With decades of experience in translational projects, including new mouse model creation and humanization, JC Discovery provides strategic custom services that drive progress and deliver tangible results.
JC Discovery is committed to optimizing drug candidates at an early stage of development through innovative approaches such as primary T cells editing and multiomics technology. With dedicated in vitro and in vivo services adhering to the 3Rs principles, JC Discovery ensures that your projects are handled with the utmost precision and care. We invite the management team at JC Discovery to enhance your company's presence and connect with a broader audience by creating a customized and exclusive company showcase and product listing on our platform.
JC Discovery est une entreprise leader dans la recherche biotechnologique, dédiée à accélérer le développement et la validation d'immunothérapies innovantes. S'appuyant sur une approche scientifique et une combinaison unique d'expertise issue de sa société fondatrice, le CIPHE (Centre d'ImmunoPHEnomics), JC Discovery offre des services inégalés aux entreprises pharmaceutiques et biotechnologiques. L'engagement de JC Discovery envers l'excellence se reflète dans sa plateforme de pointe et son laboratoire BSL3, permettant des solutions efficaces et innovantes pour la validation précoce des médicaments candidats.
Située au 163 Av. de Luminy, Marseille, 13007, FR, JC Discovery se spécialise dans l'élucidation des mécanismes d'action et des interactions, l'identification, la validation et la priorisation de nouvelles cibles thérapeutiques dans les domaines de l'immuno-oncologie, des maladies inflammatoires, auto-immunes et infectieuses. Forte de décennies d'expérience dans les projets translationnels, notamment la création et l'humanisation de nouveaux modèles de souris, JC Discovery propose des services personnalisés stratégiques qui stimulent le progrès et fournissent des résultats tangibles.
JC Discovery s'engage à optimiser les médicaments candidats à un stade précoce de développement grâce à des approches innovantes telles que l'édition de lymphocytes T primaires et la technologie multiomique. Avec des services in vitro et in vivo dédiés, respectant les principes des 3R, JC Discovery garantit que vos projets sont traités avec la plus grande précision et le plus grand soin. Nous invitons l'équipe de direction de JC Discovery à renforcer la présence de votre entreprise et à vous connecter avec un public plus large en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare JC Discovery with 3 companies in Biotechnology-Research
| Comparison Field |
JC DiscoveryMain Company |
Poseida Therapeutics...View Profile |
CDR-Life Inc.View Profile |
Enterprise Therapeut...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2017 | 2014 |
|
Company Size
|
— | 201-500 | 51-200 | 2-10 |
|
City
|
San Diego, California | Horgen, Zurich | Brighton, East Sussex | |
|
Country
|
United States | Switzerland | United Kingdom | |
|
Skills & Keywords
Comparing with main company
|
34 Total Skills
Biotechnology
Immunotherapy
Drug Development
Immuno-oncology
Translational Research
Drug Discovery
Mouse Models
Predictive models
Drug development
Humanized mouse models
Fast-Track Delivery
Fast-Track design
Humanized models
CAR-NK cells
Knock-in mice
Tumor microenvironnement
CAR-T cells
High content flow cytometry
Immunophenomics
Knock-out mice
Challenge testing
Lead candidate
Fast-Track Immunomics
Drug profiling
Drug target validation
Drug mechanism of action
BSL3
CIPHE
Translational research
Drug discovery
Bispecific antibodies
Fast-Track Breeding
Functional GEM
Functional HU-GEM
|
22 Total
2 Common
20 Unique
Match
6%
Common Skills:
Biotechnology
Immunotherapy
Unique Skills:
Adoptive Cell Therapy
Allogeneic
Cas-CLOVER™
Cell Therapy
Cytotoxic T Lymphocytes
Gene Editing
+14
|
8 Total
1 Common
7 Unique
Match
3%
Common Skills:
Biotechnology
Unique Skills:
Antibody fragments
Cancer
Entrepreneurship
Oncology
Ophthalmology
Targeted immuno-therapies
+1
|
4 Total
4 Unique
Unique Skills:
Cystic fibrosis
Epithelial cell biology
Ion channel pharmacology
Medicinal chemistry
|
4
Total Companies2014
Oldest Founded3
Countries64
Unique SkillsSimilar Companies
Other organizations in the same industry
Systems Biology Ireland
Biotechnology-ResearchPersonalising oncology through network #Biology | Based in @UCDdublin | New therapeutic approaches t...
PDC Therapeutics
Biotechnology-ResearchBiotechnology start-up developing targeted Polymer-Drug Conjugate platform technologies, named Sagit...
Alternative Company Names
This company is also known as